Transdermal Research Pharm Laboratories, LLC (TRPL) is an R&D company founded in May 2013, which has state of art R&D facility located in Long Island City, NY. TRPL is focusing on developing transdermal drug delivery systems for new chemical entities (NCE) and approved drug products.  TRPL offers its sole expertise in developing Topical/Transdermal Drug delivery system as a pharmaceutical development solution for various disease models. Our scientific staff has more than 70 years of experience in developing Transdermal Drug delivery System. And we are capable of developing Transdermal/Topical formulations as per your needs.  TRPL already rewarded with one patent and it was already out-licensed. In addition, TRPL already submitted two more patents, which is currently available for out-licensed and Four more patents are already in the pipeline which an be available for co-development.  In four year spam, TRPL put three drug candidates in the clinical trial. Two candidate pass the Phase-I clinical trial and currently under review by FDA. Potential partners who are looking to deliver complex NCE or approved drug product through skin than our expertise and technology platforms will help to develop controlled and long-term released formulation to increase the bioavailability of their API. TRPL is also interested in providing fee-based contract service with other pharmaceutical companies or investors to bring their product to the market quickly.